Renalytix Plc (RNLXY)
2.71
-0.06
(-1.99%)
USD |
OTCM |
Aug 21, 16:00
Renalytix Enterprise Value
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 22.27M |
| August 20, 2026 | 22.75M |
| August 19, 2026 | 22.66M |
| August 18, 2026 | 23.27M |
| August 17, 2026 | 23.27M |
| August 14, 2026 | 22.83M |
| August 13, 2026 | 21.65M |
| August 12, 2026 | 23.09M |
| August 11, 2026 | 24.80M |
| August 10, 2026 | 26.99M |
| August 07, 2026 | 22.79M |
| August 06, 2026 | 20.40M |
| August 05, 2026 | 17.97M |
| August 04, 2026 | 16.85M |
| August 03, 2026 | 17.28M |
| July 31, 2026 | 15.19M |
| July 30, 2026 | 15.31M |
| July 29, 2026 | 15.71M |
| July 28, 2026 | 15.71M |
| July 27, 2026 | 14.80M |
| July 24, 2026 | 15.19M |
| July 23, 2026 | 14.14M |
| July 22, 2026 | 16.06M |
| July 21, 2026 | 16.06M |
| July 20, 2026 | 15.71M |
| Date | Value |
|---|---|
| July 17, 2026 | 14.75M |
| July 16, 2026 | 14.79M |
| July 15, 2026 | 15.19M |
| July 14, 2026 | 15.27M |
| July 13, 2026 | 16.63M |
| July 10, 2026 | 16.23M |
| July 09, 2026 | 16.23M |
| July 08, 2026 | 16.23M |
| July 07, 2026 | 16.41M |
| July 06, 2026 | 16.41M |
| July 02, 2026 | 13.96M |
| July 01, 2026 | 13.44M |
| June 30, 2026 | 10.82M |
| June 29, 2026 | 9.985M |
| June 26, 2026 | 8.849M |
| June 25, 2026 | 8.62M |
| June 24, 2026 | 8.62M |
| June 23, 2026 | 9.111M |
| June 22, 2026 | 8.893M |
| June 18, 2026 | 8.630M |
| June 17, 2026 | 8.630M |
| June 16, 2026 | 8.630M |
| June 15, 2026 | 9.015M |
| June 12, 2026 | 9.504M |
| June 11, 2026 | 8.963M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| CompuMed, Inc. | 7.985M |
| Quest Diagnostics, Inc. | 33.02B |
| Labcorp Holdings, Inc. | 33.85B |
| Myriad Genetics, Inc. | 401.22M |
| OPKO Health, Inc. | 1.201B |